Gastric Volumes by US in Term Parturients Undergoing CS With and Without Metoclopramide
Status:
Recruiting
Trial end date:
2024-04-01
Target enrollment:
Participant gender:
Summary
Our objective is to compare gastric volumes (mL) between women who receive metoclopramide
versus placebo prior to scheduled cesarean delivery in appropriately fasted patients. If
metoclopramide is found not to reduce gastric volumes this would inform future practice
guidelines for obstetric anesthesia, which currently recommends metoclopramide administration
prior to cesarean deliveries.
We hypothesize that metoclopramide given to women with appropriate fasting prior to cesarean
delivery does not result in any clinically significant reduction in gastric volume (mL) and
therefore does not provide any additional benefit for aspiration prophylaxis but may expose
patients to unnecessary side effects. A secondary objective will be to evaluate if gastric
volume is a significant predictor of intraoperative nausea and vomiting.